FLAGSHIP HARBOR ADVISORS, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1691766
BOSTON, MA
Position in ARWR
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$416,597
+$412,747 QoQ
Shares Held
5,111
+8712.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#36
of 83 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FLAGSHIP HARBOR ADVISORS, LLC holds $2,839,268 across 7 Biotechnology names. ARWR ranks #4 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,669 | $829,042 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
38,378 | $651,274 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
702 | $437,725 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
5,111 | $416,597 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
7,966 | $374,720 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
18,400 | $67,528 | |
| 7 | GERN |
Geron Corp
|
48,736 | $62,382 |
All Filings in ARWR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $416,597 | 5,111 | Shares | Sole | 2026-07-22 | |
| 2025-12-31 | $3,850 | 58 | Shares | Sole | 2026-01-21 | |
| 2020-09-30 | $3,100 | 72 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,109 | 72 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $2,071 | 72 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||